自身免疫性肝病的治疗药物研究进展  

Recent Progress in Therapeutic Drugs of Autoimmune Liver Diseases

作　　者：阎俪 马雄[1,2] YAN Li;MA Xiong(Division of Gastroenterology and Hepatology,Ren.ji Hospital,Shanghai Jiao Tong University,School of Medicine Shanghai 200001,China;Shanghai Institute of Digestive Disease,Shanghai 200001,China)

机构地区：[1]上海交通大学医学院附属仁济医院消化科,上海200001 [2]上海市消化疾病研究所,上海200001

出　　处：《药学进展》2018年第5期333-336,共4页Progress in Pharmaceutical Sciences

摘　　要：自身免疫性肝病是一组由自身免疫介导的肝脏炎症性疾病,主要包括自身免疫性肝炎、原发性胆汁性胆管炎及原发性硬化性胆管炎等。近年来,自身免疫性肝病逐渐成为肝病领域的研究热点,其治疗药物的研究也有了新的突破。综述自身免疫性肝病治疗药物的研究进展。Autoimmune liver diseases are a group of autoimmune-induced inflammatory liver diseases, mainly including autoimmune hepatitis, primary biliary cholangitis and primary sclerosing cholangitis. Recently, autoimmune liver diseases have become the research focus in the field of liver disease, with new breakthroughs in the development of therapeutic drugs. This article reviewed the research progress in therapeutic drugs of autoimmune liver diseases.

关 键 词：肝病 自身免疫性 原发性胆汁性胆管炎 原发性硬化性胆管炎 治疗药物 

分 类 号：R575[医药卫生—消化系统]